^
    BIOMARKER:

    HER-2 amplification

    i
    Other names: ERBB2, CD340, HER-2, HER2, NEU, NGL, V-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2




    Show legend

    Include preclinical:
    HER2 Positive Breast Cancer
    Colorectal Cancer
    Breast Cancer
    Solid Tumor
    Non Small Cell Lung Cancer
    Gastric Cancer
    Hormone Receptor Positive Breast Cancer
    Cholangiocarcinoma
    Gastroesophageal Junction Adenocarcinoma
    Salivary Gland Cancer
    Ovarian Cancer
    Lung Adenocarcinoma
    Endometrial Cancer
    Biliary Tract Cancer
    Rectal Cancer
    Gallbladder Cancer
    Uterine Cancer
    Esophageal Cancer
    Bladder Cancer
    Lung Cancer
    Urothelial Cancer
    Gastric Adenocarcinoma
    Cutaneous Melanoma
    Esophageal Adenocarcinoma
    Gastroesophageal Cancer
    Prostate Cancer
    Pancreatic Cancer
    Melanoma
    Endometrial Adenocarcinoma
    fam-trastuzumab deruxtecan-nxki
    trastuzumab + pertuzumab
    trastuzumab + lapatinib
    ado-trastuzumab emtansine
    trastuzumab
    pyrotinib
    afatinib
    lapatinib
    neratinib
    avelumab
    pembrolizumab
    trastuzumab-qyyp
    pembrolizumab + trastuzumab
    pembrolizumab + margetuximab
    trastuzumab-pkrb
    trastuzumab-anns
    trastuzumab-dkst
    trastuzumab-dttb
    trastuzumab + avelumab
    SBT6050
    Zercepac (trastuzumab biosimilar)
    nivolumab + anlotinib + pyrotinib
    MP0274
    bevacizumab + pyrotinib
    pembrolizumab + SBT6050
    pembrolizumab + lenvatinib + pyrotinib
    trastuzumab + tucatinib
    rivoceranib + pyrotinib
    tucatinib
    KN046 + KN026
    poziotinib
    pertuzumab + ado-trastuzumab emtansine
    cabazitaxel
    disitamab vedotin
    ibrutinib
    pertuzumab/trastuzumab/hyaluronidase-zzxf
    neratinib + ado-trastuzumab emtansine
    BI 1810631
    ZW25
    dacomitinib
    panitumumab
    eFT226
    PP242
    trastuzumab + SAR245408
    cisplatin + carboplatin
    MCLA-128
    gefitinib
    olaparib + neratinib
    erlotinib
    TAS2940
    tarloxotinib bromide
    ER121
    cetuximab
    JBJ-08–178–01
    HER2 inhibitor
    Immunotherapy